This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Monster Beverage Corp. Details Medical Evidence Obtained In The Fournier Lawsuit

CORONA, Calif., March 4, 2013 (GLOBE NEWSWIRE) -- Monster Beverage Corporation (Nasdaq:MNST) today revealed the findings of a group of physicians and a coroner that the company asked to examine the medical records of Anais Fournier, whose family filed a lawsuit blaming her death on the consumption of Monster Energy Drinks.

After the lawsuit was filed, even though Monster had every confidence in the safety of its products, the company retained a group of physicians, including a coroner, to independently ascertain whether there was any basis for the allegations in the suit. The company retained a cardiac pathologist, a cardiac electrophysiologist, an emergency room physician, a chief forensic pathologist/coroner, as well as other medical experts including a toxicologist and a pharmacologist.

"After an examination of Ms. Fournier's medical records, pathology report and autopsy report, the physicians stated conclusively that there is no medical, scientific or factual evidence to support the Maryland Medical Examiner's Report of 'caffeine toxicity' or that Ms. Fournier's consumption of two Monster Energy Drinks 24 hours apart contributed to, let alone was the cause of her untimely death," said Daniel Callahan, of Callahan & Blaine, one of Monster's lawyers.

"When the Maryland Medical Examiner was asked why her report contained the term 'caffeine toxicity,' she responded that it was because she had been told by Ms. Fournier's mother that Ms. Fournier had consumed an energy drink containing caffeine," Mr. Callahan said. "This was even though her report states that blood tests for caffeine levels were not done."

"In fact, the physicians, including a coroner, we asked to examine Ms. Fournier's medical records and autopsy report found no medical, scientific or factual evidence to support a finding of caffeine toxicity," Mr. Callahan said. "They said no caffeine blood level test was performed to determine if any caffeine had been ingested. There is no medical or scientific evidence that Ms. Fournier had any caffeine in her system at the time of cardiac arrest."

1 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,868.37 -267.35 -1.47%
S&P 500 2,076.30 -24.74 -1.18%
NASDAQ 4,937.09 -45.7190 -0.92%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs